| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/19/2007 | US20070086988 Reversibly immortalized human pancreatic islet cell line containing an hTERT gene and an SV40T gene each interposed between a pair of LoxP sequences, characterized in that it is capable of producing insulin and enhancing expression of insulin after excising the hTERT gene and the SV40T gene, NAKT-13 |
| 04/19/2007 | US20070086985 Vectors for tissue-specific replication |
| 04/19/2007 | US20070086984 Viruses for the Treatment of Cellular Proliferative Disorders |
| 04/19/2007 | US20070086983 Endothelium-targeting nanoparticle for reversing endothelial dysfunction |
| 04/19/2007 | US20070086982 Gene therapy for regulating smooth muscle tone |
| 04/19/2007 | US20070086981 Delivery peptides, their constructs with active agents and use |
| 04/19/2007 | DE10248141B4 Nukleinsäuren und deren Verwendung für die Gentherapie Nucleic acids and their use for gene therapy |
| 04/19/2007 | DE10149251B4 Vorrichtung zur genetischen Immunisierung durch Einbringen von Wirkstoffen in ein Gewebe und Verfahren zur Herstellung einer Injektionslösung Apparatus for genetic immunization by introducing active substances into tissue and methods for preparing an injection solution |
| 04/19/2007 | CA2625193A1 Reconstructed living adipose tissue |
| 04/19/2007 | CA2624900A1 Fibronectin polypeptides and methods of use |
| 04/19/2007 | CA2624673A1 Allele-specific rna interference |
| 04/19/2007 | CA2624615A1 Compositions and methods for treatment of autoimmune disease |
| 04/18/2007 | EP1775343A1 Anticancer agent containing dendritic cell having rna virus transferred thereinto |
| 04/18/2007 | EP1775342A1 Anticancer agent containing minus-strand rna virus |
| 04/18/2007 | EP1774962A1 Lipid carrier and method of preparing the same |
| 04/18/2007 | EP1774326A2 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine 2a receptor (5ht2a) |
| 04/18/2007 | EP1774031A2 Cancer treatment method by inhibiting mage gene expression or function |
| 04/18/2007 | EP1774007A1 Modified virus |
| 04/18/2007 | EP1773990A2 Capsules containing transfected cells, method for preparing the same and use thereof for immunization and vaccination |
| 04/18/2007 | EP1773859A2 Methods and compositions for the inhibition of gene expression |
| 04/18/2007 | EP1773857A1 Immunostimulatory sirna molecules and uses therefor |
| 04/18/2007 | EP1773406A2 Method for screening agents against human prostate disease |
| 04/18/2007 | EP1773402A2 Improved efficacy of immunotherapy by integrating diagnostic with therapeutic methods |
| 04/18/2007 | EP1773401A1 Medical systems and methods for delivering compositions to cells |
| 04/18/2007 | EP1773373A2 Method for modulating, regulating and/or stabilizing angiogenesis |
| 04/18/2007 | EP1411970B1 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 04/18/2007 | EP1352063B1 Receptor nucleic acids and polypeptides |
| 04/18/2007 | EP1335976B1 Modifier of organelle metalbolism |
| 04/18/2007 | EP1334194B1 Imaging, diagnosis and treatment of disease |
| 04/18/2007 | EP1324652B1 Transgenic drosophila melanogaster expressing beta amyloid |
| 04/18/2007 | EP1232276B1 Vectors and transgenes with regulatory elements for gene delivery to the liver |
| 04/18/2007 | EP1206549B1 Basb119 polypeptide and polynucleotide from moraxella catarrhalis |
| 04/18/2007 | EP1012282B1 Cysteine rich receptors-train |
| 04/18/2007 | EP1005374B1 Microparticles for delivery of nucleic acid |
| 04/18/2007 | EP0960117B1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE |
| 04/18/2007 | EP0669973B2 Biological factors and neural stem cells |
| 04/18/2007 | CN1948495A Saliva streptococcus 57.I urase gene and its urase |
| 04/18/2007 | CN1948494A Prostate gland cancer cell specificity promotor and its application |
| 04/18/2007 | CN1948484A siRNA for inhibiting human hPEBP4 gene expression and its application |
| 04/18/2007 | CN1948483A SiRNA for inhibiting human Rabj gene expression and its application |
| 04/18/2007 | CN1948482A Antisensedigonucleotides sequence for inhibiting human Rabj gene expression and its application |
| 04/18/2007 | CN1947798A Method for preparing MRI visible, liver target and degradable nano-gene carrier |
| 04/18/2007 | CN1947702A Lipid carrier and method of preparing the same |
| 04/18/2007 | CN1311081C Stem cell differentiation |
| 04/18/2007 | CN1311071C A method of treating an autoimmune disease |
| 04/18/2007 | CN1310942C Suppressor gene |
| 04/18/2007 | CN1310679C Method of achieving persistent transgene expression |
| 04/17/2007 | US7205386 Truncated CD200 |
| 04/17/2007 | US7205283 Antisense oligonucleotides that inhibit expression of HIF-1 |
| 04/17/2007 | US7205278 Introducing one or more cysteine residues into a polypeptide which permit the stabilization of the polypeptide by formation of at least one bond, preferably a disulfide bond, between different domains of the polypeptide. |
| 04/17/2007 | US7205143 Feline IL-12 single chain nucleic acid molecules |
| 04/17/2007 | US7205139 Expression vector comprising nucleotide sequences coding serine protease for use in diagnosis and treatment of thrombotic disorders |
| 04/17/2007 | US7205126 Made by disrupting HPV-virus-like particles including a chelating agent, mixing them with plasmids and reassembling them into the pseudoviruses (VLPs with plasmids inside) adding a stop buffer to reassemble the VLPs into pseudoviruses; administering to the mucosa; can be applied in gene therapy |
| 04/17/2007 | US7205124 Utrophin gene promoter |
| 04/17/2007 | US7205103 Method of regulating transcription in a cell |
| 04/17/2007 | US7204991 Porphyromonas gingivalis recombinant proteins and truncations |
| 04/17/2007 | US7204979 Generation of hematopoietic cells from multipotent neural stem cells |
| 04/17/2007 | CA2231332C Bacterial delivery system |
| 04/17/2007 | CA2202477C Method, reagent and kit for evaluating susceptibility to premature atherosclerosis and treatment of same using gene therapy |
| 04/17/2007 | CA2184175C Isolated, tyrosinase derived peptides and uses thereof |
| 04/17/2007 | CA2166118C Adenovirus vectors for gene therapy |
| 04/17/2007 | CA2149420C Microporous macrocapsules |
| 04/17/2007 | CA2141212C Defective adenovirus and corresponding complementation lines |
| 04/17/2007 | CA2106819C Oligoribonucleotide and ribozyme analogs with terminal 3'-3' and/or 5'-5' linkages |
| 04/14/2007 | CA2564064A1 Genetic variations associated with psychiatric disorders |
| 04/12/2007 | WO2007041719A2 Combination therapy using budesonide and antisense oligonucleotide targeted to il4-receptor alpha |
| 04/12/2007 | WO2007041511A2 Hematopoietic progenitor kinase 1 for modulation of an immune response |
| 04/12/2007 | WO2007041497A2 Modulation of androgen receptor |
| 04/12/2007 | WO2007041495A2 Dampening humoral and innate immunity by inhibition of ppgalnact-1 |
| 04/12/2007 | WO2007041453A2 Methods and compositions for treating cancer |
| 04/12/2007 | WO2007041397A2 Targeted pharmaceuticals and ligands |
| 04/12/2007 | WO2007041350A2 Regulatable fusion promoters |
| 04/12/2007 | WO2007041282A2 Methods and compositions for treatment of cystic fibrosis |
| 04/12/2007 | WO2007041213A2 Methods for regulation of p53 translation and function |
| 04/12/2007 | WO2007041190A2 Polymer-based delivery system for immunotherapy of cancer |
| 04/12/2007 | WO2007041071A2 Oligonucleotide analogues incorporating 5-aza-cytosine therein |
| 04/12/2007 | WO2007040876A2 Methods and compositions for vaccination of animals with prrsv antigens with improved immunogenicity |
| 04/12/2007 | WO2007040469A2 Chloroquine coupled compositions and methods for their synthesis |
| 04/12/2007 | WO2007039586A1 Use of recombinant yeast strain producing an anti -inflammatory compound in the manufacture of a medicament to treat colitis |
| 04/12/2007 | WO2007038869A1 Aptamers comprising arabinose modified nucleotides |
| 04/12/2007 | WO2007021413A3 Biologic device for regulation of gene expression |
| 04/12/2007 | WO2006130855A3 Method of targeted gene delivery using viral vectors |
| 04/12/2007 | WO2006121960B1 Methods and sequences to suppress primate huntington gene expression |
| 04/12/2007 | WO2006102901A3 Immunogenic egfr peptides comprising foreign t cell stimulating epitope |
| 04/12/2007 | WO2005047465A3 Method and antisense compound for potentiating anti-cancer agents |
| 04/12/2007 | US20070082866 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 04/12/2007 | US20070082865 Compositions and methods for treatment of airway hypersecretion |
| 04/12/2007 | US20070082864 Method for inducing a specific rnai activity in cells and nucleic acids for carrying out said method |
| 04/12/2007 | US20070082863 Methods and compositions for maturing dendritic cells utilizing inosine-containing compounds |
| 04/12/2007 | US20070082862 Novel antisense oligonucleotide and anti-hiv agent |
| 04/12/2007 | US20070082861 Ena nucleic acid drugs modifying splicing in mrna precursor |
| 04/12/2007 | US20070082860 Hla-a24-restricted cancer antigen peptides |
| 04/12/2007 | US20070082846 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 04/12/2007 | US20070082845 Ferritin as a therapeutic target in abnormal cells |
| 04/12/2007 | US20070082341 Human phospholipases |
| 04/12/2007 | US20070082334 Nucleotide and protein sequence of mammastatin and methods of use |
| 04/12/2007 | US20070082009 Methods of preparation of live attenuated bacterial vaccine by alteration of dna adenine methylase (dam) activity in those bacteria |
| 04/12/2007 | US20070082000 administering to the mammal with at a site of neoangiogenesis, a pharmaceutical preparation comprising a polypeptide containing a truncated extracellular D1-1 polypeptide |
| 04/12/2007 | US20070081997 Diagnostics and therapeutics for diseases associated with kallikrein 9 (klk9) |
| 04/12/2007 | US20070081987 And GD domains by determining if agent inhibits or augments heterodimerization of polypeptides; use in diagnosis of degenerative disorders (inflammatory conditions, cancer) |